Evidence map›Paper›PMID 33754510›Full record

ArticleJournal of Korean medical science2021

Effect of Transport Time on the Use of Reperfusion Therapy for Patients with Acute Ischemic Stroke in Korea.

Jay Chol Choi, Joong Goo Kim, Chul Hoo Kang, Hee Joon Bae, Jihoon Kang, Soo Joo Lee, Jong Moo Park, Tai Hwan Park, Yong Jin Cho, Kyung Bok Lee and 7 more

Abstract read
In one paragraph

Article in Journal of Korean medical science, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors.

Jay Chol ChoiDepartment of Neurology, Jeju National University Hospital, Jeju National University College of Medicine, Jeju, Korea.ORCID https://orcid.org/0000-0002-3550-2196
Joong Goo KimDepartment of Neurology, Jeju National University Hospital, Jeju National University College of Medicine, Jeju, Korea.ORCID https://orcid.org/0000-0002-4166-6023
Chul Hoo KangDepartment of Neurology, Jeju National University Hospital, Jeju National University College of Medicine, Jeju, Korea.ORCID https://orcid.org/0000-0002-4176-0941
Hee Joon BaeDepartment of Neurology, Seoul National University Bundang Hospital, Seoul National University College of Medicine, Seongnam, Korea.ORCID https://orcid.org/0000-0003-0051-1997
Jihoon KangDepartment of Neurology, Seoul National University Bundang Hospital, Seoul National University College of Medicine, Seongnam, Korea.ORCID https://orcid.org/0000-0001-5715-6610
Soo Joo LeeDepartment of Neurology, Eulji University Hospital, Daejeon, Korea.ORCID https://orcid.org/0000-0001-8622-7000
Jong Moo ParkDepartment of Neurology, Eulji General Hospital, Eulji University, Seoul, Korea.ORCID https://orcid.org/0000-0002-4199-3024
Tai Hwan ParkDepartment of Neurology, Seoul Medical Center, Seoul, Korea.ORCID https://orcid.org/0000-0002-5148-1663
Yong Jin ChoDepartment of Neurology, Ilsan Paik Hospital, Inje University, Goyang, Korea.ORCID https://orcid.org/0000-0002-7843-1148
Kyung Bok LeeDepartment of Neurology, Soonchunhyang University College of Medicine, Seoul, Korea.ORCID https://orcid.org/0000-0003-2663-7483
Jun LeeDepartment of Neurology, Yeungnam University Hospital, Daegu, Korea.ORCID https://orcid.org/0000-0001-8643-0797
Dong Eog KimDepartment of Neurology, Dongguk University Ilsan Hospital, Goyang, Korea.ORCID https://orcid.org/0000-0002-9339-6539
Jae Kwan ChaDepartment of Neurology, Dong-A University College of Medicine, Busan, Korea.ORCID https://orcid.org/0000-0002-1049-5196
Joon Tae KimDepartment of Neurology, Chonnam National University Hospital, Chonnam National University Medical School, Gwangju, Korea.ORCID https://orcid.org/0000-0003-4028-8339
Byung Chul LeeDepartment of Neurology, Hallym University Sacred Heart Hospital, Anyang, Korea.ORCID https://orcid.org/0000-0002-3885-981X
Ji Sung LeeClinical Research Center, Asan Medical Center, Seoul, Korea.ORCID https://orcid.org/0000-0001-8194-3462
Anthony S KimDepartment of Neurology, University of California San Francisco, San Francisco, CA, USA.ORCID https://orcid.org/0000-0002-8095-6517

Funding

Jeju National University Hospital
6 · The paper itself

Abstract

backgroundWe investigated the association between geographic proximity to hospitals and the administration rate of reperfusion therapy for acute ischemic stroke.

methodsWe identified patients with acute ischemic stroke who visited the hospital within 12 hours of symptom onset from a prospective nationwide multicenter stroke registry. Reperfusion therapy was classified as intravenous thrombolysis (IVT), endovascular therapy (EVT), or combined therapy. The association between the proportion of patients who were treated with reperfusion therapy and the ground transport time was evaluated using a spline regression analysis adjusted for patient-level characteristics. We also estimated the proportion of Korean population that lived within each 30-minute incremental service area from 67 stroke centers accredited by the Korean Stroke Society.

resultsOf 12,172 patients (mean age, 68 ± 13 years; men, 59.7%) who met the eligibility criteria, 96.5% lived within 90 minutes of ground transport time from the admitting hospital. The proportion of patients treated with IVT decreased significantly when stroke patients lived beyond 90 minutes of the transport time (

conclusionThe use of reperfusion therapy for acute stroke decreased when patients lived beyond 90 minutes of the ground transport time from the hospital. More than 95% of the South Korean population was accessible to 67 stroke centers within 90 minutes of the ground transport time.

Indexed as

Endovascular ProceduresThrombolytic TherapyTime-to-TreatmentAdministration, IntravenousAgedAged, 80 and overCombined Modality TherapyFemaleFibrinolytic AgentsHumansIschemic StrokeMaleMiddle AgedRegistriesRepublic of KoreaTime FactorsFibrinolytic AgentsEndovascular TreatmentIschemic StrokeReperfusionThrombolysisUtilization

Identifiers

PMID33754510
PMCPMC7985286

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.